BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 6351444)

  • 1. [Immunopathology of lymphatic systemic diseases].
    Huber H; Gattringer C
    Wien Klin Wochenschr; 1983 May; 95(10):319-26. PubMed ID: 6351444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunocytologic diagnosis of leukemia and lymphoma: monoclonal antibodies in the differential diagnosis of hematologic neoplasms].
    Huber H; Gattringer C; Thaler J; Peschel C
    Behring Inst Mitt; 1985 Dec; (78):83-117. PubMed ID: 3914283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody studies in B(non-T)-cell malignancies.
    Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
    Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors.
    Epstein AL; Marder RJ; Winter JN; Fox RI
    J Immunol; 1984 Aug; 133(2):1028-36. PubMed ID: 6376628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Morphologic and immunologic criteria for the diagnosis of non-Hodgkin's lymphoma of low-grade malignancy].
    Odermatt BF; Maurer R; Rüttner JR
    Schweiz Rundsch Med Prax; 1986 Apr; 75(15):401-7. PubMed ID: 3485809
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunoperoxidase study of normal and pathologic lymphoid tissue. Value of monoclonal antibodies].
    Delsol G; Al Saati T; Caveriviere P; Voigt JJ; Ancelin E; Rigal-Huguet F
    Ann Pathol; 1984; 4(3):165-83. PubMed ID: 6383412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunopathology of non-Hodgkin lymphomas.
    Huber H; Gattringer C; Knapp W; Stein H
    Klin Wochenschr; 1984 Nov; 62(21):1001-10. PubMed ID: 6392723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactivity of Leu 1 and T101 monoclonal antibodies with B cell lymphomas (correlations with other immunological markers).
    Al Saati T; Laurent G; Caveriviere P; Rigal F; Delsol G
    Clin Exp Immunol; 1984 Dec; 58(3):631-8. PubMed ID: 6239721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two monoclonal antibodies raised against a Burkitt lymphoma cell line recognise different cell types within lymphoid follicles.
    Murray LJ; Dhut S; Walker LC; Rainey M; Habeshaw JA
    Clin Exp Immunol; 1985 Feb; 59(2):315-26. PubMed ID: 3872187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new monoclonal antibody (KB61) recognizing a novel antigen which is selectively expressed on a subpopulation of human B lymphocytes.
    Pulford K; Ralfkiaer E; MacDonald SM; Erber WN; Falini B; Gatter KC; Mason DY
    Immunology; 1986 Jan; 57(1):71-6. PubMed ID: 3484721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the monoclonal antibody WR17, identifying the CD37 gp40-45 Kd antigen complex, in the diagnosis of B-lymphoid malignancy.
    Moore K; Cooper SA; Jones DB
    J Pathol; 1987 May; 152(1):13-21. PubMed ID: 3305845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microtubule organization in lymphoid malignancies.
    Hirose Y; Konda S
    Blood Cells; 1992; 18(2):225-38; discussion 239-40. PubMed ID: 1450424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Determination of leukemic B-lymphoma cells with the monoclonal antibody anti-Y 29/55].
    Obrecht JP; Gudat F; Forster HK; Albrecht R; Girard MF; Ludwig C; Christen C
    Schweiz Med Wochenschr; 1981 Oct; 111(41):1529-31. PubMed ID: 6975994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunopathology of malignant lymphomas (author's transl)].
    Huber H; Gattringer C
    Arch Geschwulstforsch; 1979; 49(8):694-701. PubMed ID: 317427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody HML-1, a marker for intraepithelial T cells and lymphomas derived thereof, also recognizes hairy cell leukemia and some B-cell lymphomas.
    Möller P; Mielke B; Moldenhauer G
    Am J Pathol; 1990 Mar; 136(3):509-12. PubMed ID: 2316623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of haematological malignancies and their treatment on host defence factors.
    Hersh EV; Gutterman JU; Mavligit GM
    Clin Haematol; 1976 Jun; 5(2):425-48. PubMed ID: 780032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel monoclonal antibody (OPD4) recognizing a helper/inducer T cell subset. Its application to paraffin-embedded tissues.
    Yoshino T; Mukuzono H; Aoki H; Takahashi K; Takeuchi T; Kubonishi I; Ohtsuki Y; Motoi M; Akagi T
    Am J Pathol; 1989 Jun; 134(6):1339-46. PubMed ID: 2527008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
    Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
    Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [T-and B-lymphocytes in lymphoproliferative syndromes].
    Girard JP; Fernandes B
    Schweiz Med Wochenschr; 1975 Sep; 105(37):1174-9. PubMed ID: 814616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [T-lymphocytes in the peripheral blood and lymph nodes in lymphatic system diseases].
    Michlmayr G; Huber C; Fink U; Falkensammer M; Huber H
    Schweiz Med Wochenschr; 1974 Jun; 104(23):815-20. PubMed ID: 4546217
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.